Literature DB >> 11682058

Organic phosphates as a new class of soluble guanylate cyclase inhibitors.

T Suzuki1, M Suematsu, R Makino.   

Abstract

This study aimed to examine effects of varied organic phosphates on activities of soluble guanylate cyclase (sGC). The enzyme was purified from bovine lung. Physiologically relevant concentrations of ATP, 2,3-bisphosphoglyceric acid and inositol hexakisphosphate inhibited its enzyme activities under steady-state conditions as well as those determined under stimulation with S-nitroso-N-acetylpenicillamine, a nitric oxide donor, carbon monoxide or YC-1. Lineweaver-Burk plot analyses revealed that these three organic phosphates act as competitive inhibitors. Other organic phosphates such as cardiolipin and sphingomyelin but not inorganic phosphates exhibited such inhibitory actions. These results suggest that organic phosphates serve as inhibitors for sGC-dependent signaling events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682058     DOI: 10.1016/s0014-5793(01)02943-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.

Authors:  Nur Başak Sürmeli; Frederike M Müskens; Michael A Marletta
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

Review 2.  Nitric oxide signaling in the microcirculation.

Authors:  Donald G Buerk; Kenneth A Barbee; Dov Jaron
Journal:  Crit Rev Biomed Eng       Date:  2011

3.  Modulation of perfusion and oxygenation by red blood cell oxygen affinity during acute anemia.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-20       Impact factor: 6.914

4.  Nucleotide regulation of soluble guanylate cyclase substrate specificity.

Authors:  Emily R Derbyshire; Nathaniel B Fernhoff; Sarah Deng; Michael A Marletta
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.